Skip to content
10-K

Annual Report

KIORA PHARMACEUTICALS INC KPHMW KPRX

0001372514-26-000024

← back to feed
Filed
Mar 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 21, 2026 3.95M sh
Shares Diluted FY 2025 · Dec 31, 2025 4.1M sh
Shares Diluted FY 2025 · Dec 31, 2024 4.13M sh
Capex FY 2025 · Dec 31, 2025 $110.79K
Capex FY 2025 · Dec 31, 2024 $6.26K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$9.96M
Operating Cash Flow FY 2025 · Dec 31, 2024 $8.56M
Short Term Investments FY 2025 · Dec 31, 2025 $8.39M
Short Term Investments FY 2025 · Dec 31, 2024 $23M
Cash And Equivalents FY 2025 · Dec 31, 2025 $8.7M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.79M
Stockholders Equity FY 2025 · Dec 31, 2025 $16.13M
Stockholders Equity FY 2025 · Dec 31, 2024 $25.76M
Stockholders Equity FY 2025 · Dec 31, 2023 $6.11M
Current Liabilities FY 2025 · Dec 31, 2025 $3.63M
Current Liabilities FY 2025 · Dec 31, 2024 $6.01M
Total Liabilities FY 2025 · Dec 31, 2025 $8.13M
Total Liabilities FY 2025 · Dec 31, 2024 $10.72M
Current Assets FY 2025 · Dec 31, 2025 $21.75M
Current Assets FY 2025 · Dec 31, 2024 $29.71M
Total Assets FY 2025 · Dec 31, 2025 $24.25M
Total Assets FY 2025 · Dec 31, 2024 $36.48M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.64
Eps Diluted FY 2025 · Dec 31, 2024 $0.87
Eps Basic FY 2025 · Dec 31, 2025 −$2.60
Eps Basic FY 2025 · Dec 31, 2024 $0.93
Sga Expense FY 2025 · Dec 31, 2025 $5.75M
Sga Expense FY 2025 · Dec 31, 2024 $5.54M
Rd Expense FY 2025 · Dec 31, 2025 $10.78M
Rd Expense FY 2025 · Dec 31, 2024 $7.84M
Net Income FY 2025 · Dec 31, 2025 −$10.84M
Net Income FY 2025 · Dec 31, 2024 $3.59M
Operating Income FY 2025 · Dec 31, 2025 −$12.83M
Operating Income FY 2025 · Dec 31, 2024 $4.51M